Q1 results put Chimera Investment (CIM) in focus

Chimera Investment (CIM) has moved onto investors’ radar after first quarter 2026 results, where HomeXpress origination volume rose 39% year over year and portfolio shifts toward Agency RMBS were paired with an emphasis on dividend growth.

Following the Q1 update, Chimera Investment’s share price is at $13.28, with a year-to-date share price return of 4.24%. The 1-year total shareholder return of 10.50% contrasts with a 5-year total shareholder return that is down 48.59%, suggesting recent momentum has picked up after a weaker longer-term experience for holders.

If Chimera’s latest move has you thinking about where else income and credit themes could lead, it might be a good time to scan 21 top founder-led companies

With Chimera trading at $13.28, sitting at a discount to analyst targets and an indicated intrinsic value gap, the key question is whether this reflects a genuine mispricing or whether the market already anticipates future growth.

Most Popular Narrative: 8.4% Undervalued

With Chimera Investment last closing at $13.28 against a widely followed fair value estimate of $14.50, the core question is how that gap is justified and what assumptions sit behind it.

The acquisition of HomeXpress, a leading non-QM originator, is expected to be materially accretive to earnings in 2026 and 2027, aligning with the ongoing expansion of the non-agency and non-QM mortgage markets. This is expected to directly influence revenue and return on equity.

Want to see what sits under that valuation gap? The most followed narrative focuses on expectations for revenue, margins, and a lower future earnings multiple than the sector.

Result: Fair Value of $14.50 (UNDERVALUED)

However, the narrative could be challenged if higher credit losses from non agency mortgage exposure, or funding stress from short term repo markets, start to bite.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another take on valuation

The DCF view suggests Chimera is trading at a 52.1% discount to an estimated future cash flow value of $27.71, while analysts see only an 11.7% discount to their $14.83 price target. When one model points to a wide gap and another looks modest, which signal should be treated as more important?

Next Steps

If this mix of opportunity and concern feels familiar, it is because Chimera sits at the crossroads of income potential and credit risk. Move quickly to test the numbers, pressure test your own assumptions, and weigh the stock’s 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If Chimera has sharpened your focus on income and credit themes, do not stop here. Broaden your watchlist with other opportunities that might fit your goals.

• Spot potential value opportunities early by checking out the 47 high quality undervalued stocks that line up strong fundamentals with pricing that has not fully caught up yet.
• Build a steadier income base by reviewing the 10 dividend fortresses that aim to pair higher yields with more resilient payout records.
• Sleep easier at night by scanning the 65 resilient stocks with low risk scores that show lower overall risk scores while still offering equity upside.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.